Navigation Links
United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Date:12/27/2011

NEW YORK, Dec. 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739472/United-States-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the United States Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the two market categories.

- Global corporate-level profiles of key companies operating within the United States Diabetes Care Devicesmarket.

- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Inc., Bayer HealthCare AG, Abbott Laboratories, Becton, Dickinson and Company and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the United States Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Diabetes Care Devices In United States 12

3.1 Diabetes Care Devices, Market Segmentation 12

3.2 Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13

3.3 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2010 14

3.4 Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15

3.5 Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22

3.6 Diabetes Care Devices, United States, Company share (2009-2010) 26

4 Glucose Monitoring In United States 28

4.1 Glucose Monitoring, Market Segmentation 28

4.2 Glucose Monitoring Market, United States, Revenue Mix ($m), 2010 29

4.3 Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30

4.4 Glucose Monitoring Overall Revenue (2003-2017) 31

4.4.1 Blood Glucose Meters Revenue (2003-2017) 35

4.5 Glucose Monitoring Overall Volume (2003-2017) 39

4.5.1 Blood Glucose Meters Volume (2003-2017) 43

4.6 Glucose Monitoring Average Price (2003-2017) 47

4.7 Glucose Monitoring Distribution Share (2009-2010) 48

4.8 Glucose Monitoring, United States, Company share (2009-2010) 49

5 Insulin Delivery In United States 51

5.1 Insulin Delivery, Market Segmentation 51

5.2 Insulin Delivery Market, United States, Revenue Mix ($m), 2010 52

5.3 Insulin Delivery Market, United States, Segment Contribution (%), 2010 53

5.4 Insulin Delivery Overall Revenue (2003-2017) 54

5.4.1 Insulin Pens Revenue (2003-2017) 58

5.4.2 Insulin Pumps Revenue (2003-2017) 62

5.5 Insulin Delivery Overall Volume (2003-2017) 66

5.5.1 Insulin Pens Volume (2003-2017) 70

5.5.2 Insulin Pumps Volume (2003-2017) 74

5.6 Insulin Delivery Average Price (2003-2017) 78

5.7 Insulin Delivery Distribution Share (2009-2010) 80

5.8 Insulin Delivery, United States, Company share (2009-2010) 81

6 Overview of Key Companies in United States Diabetes Care Devices Market 83

6.1 LifeScan, Inc. 83

6.1.1 Company Overview 83

6.1.2 Share in the United States Diabetes Care Devices Market 83

6.2 Medtronic, Inc. 84

6.2.1 Company Overview 84

6.2.2 Share in the United States Diabetes Care Devices Market 84

6.3 F. Hoffmann-La Roche Ltd. 85

6.3.1 Company Overview 85

6.3.2 Share in the United States Diabetes Care Devices Market 85

6.4 Bayer HealthCare AG 86

6.4.1 Company Overview 86

6.4.2 Share in the United States Diabetes Care Devices Market 86

6.5 Abbott Laboratories 87

6.5.1 Company Overview 87

6.5.2 Share in the United States Diabetes Care Devices Market 87

6.6 Becton, Dickinson and Company 88

6.6.1 Company Overview 88

6.6.2 Share in the United States Diabetes Care Devices Market 88

6.7 Eli Lilly and Company 89

6.7.1 Company Overview 89

6.8 Animas Corporation 89

6.8.1 Company Overview 89

6.9 Novo Nordisk A/S 89

6.9.1 Company Overview 89

6.10 Sanofi 90

6.10.1 Company Overview 90

6.11 Insulet Corporation 90

6.11.1 Company Overview 90

6.12 NIPRO CORPORATION 91

6.12.1 Company Overview 91

6.13 ARKRAY, Inc. 91

6.13.1 Company Overview 91

7 Diabetes Care Devices Market Pipeline Products 92

8 Financial Deals Landscape 98

8.1 Acquisition 98

8.1.1 Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 98

8.1.2 Insulet Acquires Neighborhood Diabetes 99

8.1.3 Sanare Acquires Doctor Diabetic Supply 100

8.2 Partnerships 101

8.2.1 Roche Diagnostics Enters Into Distribution Agreement With DexCom 101

8.2.2 Roche Diagnostics Enters Into Research And Development Agreement With DexCom 102

8.2.3 CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 103

8.2.4 Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 104

8.2.5 PositiveID Enters Into Agreement With HMD BioMedical 105

8.2.6 Perrigo Enters Into Distribution Agreement With AgaMatrix 106

8.2.7 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 107

8.2.8 Midatech Enters Into Joint Venture With MonoSol Rx 108

9 Recent Developments 109

9.1 Strategy And Business Planning 109

9.1.1 Oct 19, 2011: Abbott To Separate Into Two Leading Companies In Diversified Medical Products And Research-Based Pharmaceuticals 109

9.1.2 Oct 13, 2011: Unisense Establishes US Headquarter 110

9.1.3 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California 111

9.1.4 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China 111

9.1.5 Feb 03, 2011: LHC Group Announces Home Health Joint Venture With Baptist Hospital In Pensacola, Florida 112

9.1.6 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 112

9.2 Legal and Regulatory 113

9.2.1 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira 113

9.2.2 Jul 11, 2011: Retractable Technologies Announces Decision From United States Court of Appeals for the Federal Circuit 113

9.2.3 Jun 08, 2011: US District Court Rules In Favor Of Lilly In Amylin Litigation 114

9.2.4 May 25, 2011: Lilly Comments On Court Ruling In Amylin Litigation 114

9.2.5 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 114

9.2.6 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 115

9.2.7 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities 115

9.3 Government and Public Interest 116

9.3.1 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech Industry Conference 116

9.3.2 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To Treatments For Type 2 Diabetes 117

9.3.3 Sep 14, 2011: Medtronic Pledges Action In Advance of United Nations High Level Meeting On Noncommunicable Diseases 117

9.3.4 Sep 08, 2011: Sanmina-SCI Kenosha, Wisconsin Facility Receives ISO 13485 Certification For Medical Devices 118

9.3.5 Jul 14, 2011: Lilly And Argonne National Laboratory Announce $2m Upgrade To Lilly's Beamline Capabilities 118

9.3.6 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections 119

9.3.7 Apr 08, 2011: MannKind Provides Regulatory Update 120

9.3.8 Mar 09, 2011: Medtronic Resolves FDA Warning Letters 120

9.3.9 Feb 25, 2011: Breastfeeding Babies Exposed To Diabetes In Utero Protects Against Childhood Obesity: Study 120

9.3.10 Jan 27, 2011: Guided Therapeutics Receives ISO Certification 121

9.3.11 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 121

9.3.12 Dec 22, 2010: Abbott Recalls Certain Lots Of Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ And ReliOn Ultima Blood Glucose Test Strips In US And Puerto Rico 123

9.3.13 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 124

9.4 Product News 125

9.4.1 Oct 28, 2011: ARKRAY's GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed On DoD Uniform Formulary 125

9.4.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed Paradigm REAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In Diabetic Patients 125

9.4.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigm x54 System 126

9.4.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time Revel System 127

10 Appendix 128

10.1 Definitions of Markets Covered in the Report 129

10.1.1 Diabetes Care Devices 129

10.2 Research Methodology 132

10.3 Secondary Research 132

10.4 Primary Research 133

10.5 Models 133

10.6 Forecasts 134

10.7 Expert Panels 134

10.8 GlobalData Consulting 134

10.9 Contact Us 135

10.10 Disclaimer 135

List of Tables

Table 1: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13

Table 2: Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15

Table 3: Diabetes Care Devices, United States, Cross-Segment Analysis,2002-2016 17

Table 4: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 19

Table 5: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 21

Table 6: Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22

Table 7: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 24

Table 8: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 25

Table 9: Diabetes Care Devices, United States, Company share by Revenue ($m), USD Actual, 2009-2010 27

Table 10: Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30

Table 11: Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 32

Table 12: Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 34

Table 13: Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 36

Table 14: Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 38

Table 15: Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2003-2010 40

Table 16: Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2010-2017 42

Table 17: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 44

Table 18: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 46

Table 19: Glucose Monitoring, United States, Average Price ($), Historic, 2003-2010 47

Table 20: Glucose Monitoring, United States, Average Price ($), Forecast, 2010-2017 47

Table 21: Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 48

Table 22: Glucose Monitoring, United States, Company share by Revenue ($m), USD Actual 2009-2010 50

Table 23: Insulin Delivery Market, United States, Segment Contribution (%), 2010 53

Table 24: Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 55

Table 25: Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 57

Table 26: Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 59

Table 27: Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 61

Table 28: Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 63

Table 29: Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 65

Table 30: Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2003-2010 67

Table 31: Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2010-2017 69

Table 32: Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 71

Table 33: Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 73

Table 34: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 75

Table 35: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 77

Table 36: Insulin Delivery, United States, Average Price ($), Historic, 2003-2010 78

Table 37: Insulin Delivery, United States, Average Price ($), Forecast, 2010-2017 79

Table 38: Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80

Table 39: Insulin Delivery, United States, Company share by Revenue ($m), USD Actual 2009-2010 82

Table 40: Diabetes Care Devices Market Pipeline Products 92

Table 41: Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 98

Table 42: Insulet Acquires Neighborhood Diabetes 99

Table 43: Sanare Acquires Doctor Diabetic Supply 100

Table 44: Roche Diagnostics Enters Into Distribution Agreement With DexCom 101

Table 45: Roche Diagnostics Enters Into Research And Development Agreement With DexCom 102

Table 46: CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 103

Table 47: Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 104

Table 48: PositiveID Enters Into Agreement With HMD BioMedical 105

Table 49: Perrigo Enters Into Distribution Agreement With AgaMatrix 106

Table 50: ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 107

Table 51: Midatech Enters Into Joint Venture With MonoSol Rx 108

List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation 12

Figure 2: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 13

Figure 3: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2010 14

Figure 4: Diabetes Care Devices Market, United States, Category Contribution (%), 2010 15

Figure 5: Diabetes Care Devices, United States, Cross-Segment Analysis,2003-2017 16

Figure 6: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 18

Figure 7: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 20

Figure 8: Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 22

Figure 9: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 23

Figure 10: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 25

Figure 11: Diabetes Care Devices, United States, Company share (%), 2010 26

Figure 12: Glucose Monitoring, Market Segmentation 28

Figure 13: Glucose Monitoring Market, United States, Revenue Mix ($m), 2010 29

Figure 14: Glucose Monitoring Market, United States, Segment Contribution (%), 2010 30

Figure 15: Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 31

Figure 16: Glucose Monitoring, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 33

Figure 17: Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 35

Figure 18: Blood Glucose Meters, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 37

Figure 19: Glucose Monitoring, United States, Volume (Units) by Segment, Historic, 2003-2010 39

Figure 20: Glucose Monitoring, United States, Volume (Units) by Segment, Forecast, 2010-2017 41

Figure 21: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 43

Figure 22: Blood Glucose Meters, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 45

Figure 23: Glucose Monitoring, United States, Company share (%), 2010 49

Figure 24: Insulin Delivery, Market Segmentation 51

Figure 25: Insulin Delivery Market, United States, Revenue Mix ($m), 2010 52

Figure 26: Insulin Delivery Market, United States, Segment Contribution (%), 2010 53

Figure 27: Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 54

Figure 28: Insulin Delivery, United States, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 56

Figure 29: Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 58

Figure 30: Insulin Pens, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 60

Figure 31: Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010 62

Figure 32: Insulin Pumps, United States, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017 64

Figure 33: Insulin Delivery, United States, Volume (Units) by Segment, Historic, 2003-2010 66

Figure 34: Insulin Delivery, United States, Volume (Units) by Segment, Forecast, 2010-2017 68

Figure 35: Insulin Pens, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 70

Figure 36: Insulin Pens, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 72

Figure 37: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Historic, 2003-2010 74

Figure 38: Insulin Pumps, United States, Volume (Units) by Sub-Segment, Forecast, 2010-2017 76

Figure 39: Insulin Delivery, United States, Company share (%), 2010 81

Figure 40: LifeScan, Inc., Company Share (%),United States Diabetes Care Devices Market, 2010 83

Figure 41: Medtronic, Inc., Company Share (%),United States Diabetes Care Devices Market, 2010 84

Figure 42: F. Hoffmann-La Roche Ltd., Company Share (%),United States Diabetes Care Devices Market, 2010 85

Figure 43: Bayer HealthCare AG, Company Share (%),United States Diabetes Care Devices Market, 2010 86

Figure 44: Abbott Laboratories, Company Share (%),United States Diabetes Care Devices Market, 2010 87

Figure 45: Becton, Dickinson and Company, Company Share (%),United States Diabetes Care Devices Market, 2010 88

Companies mentioned

LifeScan, Inc.

Medtronic, Inc.

F. Hoffmann-La Roche Ltd.

Bayer HealthCare AG

Abbott Laboratories

Becton, Dickinson and Company

Eli Lilly and Company

Animas Corporation

Novo Nordisk A/S

Sanofi

Insulet Corporation

NIPRO CORPORATION

ARKRAY, Inc.

To order this report:

Pathology Industry: United States Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. R-CALF United Stockgrowers of America: Fighting for the U.S. Cattle Producer
3. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
4. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
5. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
6. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
7. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
8. Premier Research Expands its Medical Device Operations to the United States
9. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
10. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
11. EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Wearable posture tracker, ALEX , has taken Kickstarter by ... and just seven days left to go, ALEX is said to be delivered to backers starting May ... ... ... Created by ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... , Feb. 11, 2016 PLAD, Inc. (OTC ... 2016 with sales exceeding company targets, are adding key ... their trademark from the United States Patent and Trademark ... , Chief Executive Officer of PLAD, Inc.  In January, ... Pennsylvania with two new customers, Cumberland ...
Breaking Medicine Technology:
(Date:2/12/2016)... Omaha, NE (PRWEB) , ... February 12, 2016 , ... ... list of the five most searched jobs via the website of healthcare staffing leader ... professionals in travel nurse jobs , travel therapy positions and in ...
(Date:2/12/2016)... Texas (PRWEB) , ... February 12, 2016 , ... Yisrayl ... a revealing article this week that uncovers what he says are the real facts ... stories of the Bible from parents and Sunday school teachers, and Yisrayl says there ...
(Date:2/12/2016)... ... , ... With the exception of restorative dentistry, to date there has been no other option ... by the FDA, there is a now a new protocol in stopping cavity progression; Silver ... and quick to apply. The application is as simple as drying the tooth and ...
(Date:2/11/2016)... ORLEANS (PRWEB) , ... February 11, 2016 , ... “ ... Achieving Satisfaction through a Well Managed Mind” (published by Balboa Press) teaches readers how ... way of being through profound love, author Janice McDermott, M.Ed., LCSW, offers an understanding ...
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western ... (AOA) Match Program Tuesday, February 9, taking one of the final steps in ... medical education positions across the country. Of the 103 student-doctors who comprise the ...
Breaking Medicine News(10 mins):